Urban density and HIV prevalence linked to rising antibiotic resistance in gonorrhea

Researchers identify key geographic and health factors that may predict the prevalence of antimicrobial-resistant gonorrhea in the United States.

Pharma finds TV ads are a hard habit to break. It’s still putting 65% of ad dollars into TV

Pharma companies are slowly shifting to digital advertising, but that doesn’t mean they are giving up on TV ads anytime soon, according to a recent

June 9, 2023

Traditional randomized trials don’t work for ultra-rare diseases like Barth syndrome

Another ultra-rare therapy will soon be subject to the gaze of an FDA advisory committee, with the fate of more than 200 boys diagnosed with

October 9, 2024

Linezolid ‘Not Recommended’ to Treat Early Syphilis

Linezolid failed to meet noninferiority criteria when compared with standard benzathine penicillin G (BPG) in the treatment of early syphilis, according to findings of the

January 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.